inaqovi
otsuka pharmaceutical netherlands b.v. - cedazuridine, decitabine - leukémia, mieloid - daganatellenes szerek - inaqovi is indicated as monotherapy for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) who are ineligible for standard induction chemotherapy.
vanflyta
daiichi sankyo europe gmbh - quizartinib dihydrochloride - leukémia, mieloid - antineoplastic agents, protein kinase inhibitors - vanflyta is indicated in combination with standard cytarabine and anthracycline induction and standard cytarabine consolidation chemotherapy, followed by vanflyta single-agent maintenance therapy for adult patients with newly diagnosed acute myeloid leukaemia (aml) that is flt3-itd positive.
bindren
mitsubishi pharma europe ltd - kolesztilán - hyperphosphataemia - gyógyszerek hyperkalaemia és hyperphosphataemia kezelésére - krónikus vesebetegségben szenvedő felnőtt betegek hiperfoszfatémia kezelése hemodialízis vagy peritoneális dialízis.
femoden bevont tabletta
eu pharma kft. - gestodene; ethinylestradiol -
aspirin 500 tabletta
eu pharma kft. - acetilszalicilsav -
gracial tabletta
eu pharma kft. - desogestrel; ösztradiol -
saridon tabletta
eu pharma kft. - paracetamol; propyphenazone -
voltaren emulgel 1% gél
eu pharma kft. - a diclofenac -
visine classic szemcsepp
eu pharma kft. - tetryzoline -
lendacin 2 g por injekcióhoz
eu pharma kft. - ceftriaxon -